Simulations Plus, Inc. (NASDAQ:SLP) Files An 8-K Other Events
Item 8.01Other Events
On June 15, 2017, Simulations Plus, Inc., a California
corporation (the Company), issued a press release announcing
preliminary revenues for the third fiscal quarter of fiscal year
2017 ended May 31, 2017. The press release is furnished as
Exhibit 99.1 to this Current Report on Form 8-K.
The information contained in this Current Report on Form 8-K
shall not be deemed to be filed for purposes of Section 18 of the
Securities Exchange Act of 1934, as amended (the Exchange Act),
or otherwise subject to the liabilities of that section, nor
shall such information be deemed incorporated by reference in any
filing under the Securities Act of 1933, as amended (the
Securities Act), or the Exchange Act, except as shall be
expressly set forth by specific reference in such a filing. The
information set forth in this Current Report on Form 8-K shall
not be deemed an admission as to the materiality of any
information in this report on Current Report on Form 8-K that is
required to be disclosed solely to satisfy the requirements of
Regulation FD.
CAUTION REGARDING FORWARD-LOOKING STATEMENTS
This Current Report on Form 8-K may contain forward-looking
statements that are made to the safe harbor provisions of Section
21E of the Exchange Act. The forward-looking statements in this
Current Report on Form 8-K are not historical facts, do not
constitute guarantees of future performance and are based on
numerous assumptions which, while believed to be reasonable, may
not prove to be accurate. Any forward-looking statements in this
Current Report on Form 8-K do not constitute guarantees of future
performance and involve a number of factors that could cause
actual results to differ materially, including risks more fully
described in our most recently filed Quarterly Report on Form
10-Q and Annual Report on Form 10-K. The Company assumes no
obligation to update any forward-looking information contained in
this Current Report or with respect to the announcements
described herein.
Item 9.01Financial Statements and Exhibits
(d)Exhibits
99.1Press release issued on June 15, 2017.
SIMULATIONS PLUS INC ExhibitEX-99.1 2 simulations_8k-ex9901.htm PRESS RELEASE Exhibit 99.1 For Further Information: Simulations Plus,…To view the full exhibit click here About Simulations Plus, Inc. (NASDAQ:SLP)
Simulations Plus, Inc. (Simulations Plus) develops and produces software for use in pharmaceutical research and for education, and provides consulting and contract research services to the pharmaceutical industry. The Company offers five software products for pharmaceutical research. ADMET (Absorption, Distribution, Metabolism, Excretion and Toxicity) Predictor is a computer program that takes molecular structures as inputs and predicts over 140 different properties for them at the rate of about 200,000 compounds per hour. MedChem Designer includes a small set of ADMET Predictor property predictions, allowing the chemist to modify molecular structures. MedChem Studio is a tool for medicinal and computational chemists for both data mining and for designing new drug-like molecules. DDDPlus simulates in-vitro laboratory experiments used to measure the rate of dissolution of the drug. GastroPlus simulates the absorption, pharmacokinetics, and pharmacodynamics of drugs.
